Catalog |
name |
Description |
price |
R-R-2821 |
Lotiglipron CAS No.2401892-75-7 |
Lotiglipron (PF-07081532)/CAS No.2401892-75-7 is an orally active GLP-1R agonist. Lotiglipron reduces glucose and body weight, and can be used for research of Type 2 diabetes mellitus (T2DM). |
price> |
R-R-2822 |
Exendin-4 acetate CAS No.914454-01-6 |
Exendin-4 acetate (Exenatide acetate)/CAS No.914454-01-6, a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM. |
price> |
R-R-2823 |
Retatrutide TFA |
Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity. |
price> |
R-R-2824 |
LGD-6972 CAS No.1207989-09-0 |
LGD-6972/CAS No.1207989-09-0 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research. |
price> |
R-R-2825 |
NNC-0640 CAS No.307986-98-7 |
NNC-0640/CAS No.307986-98-7 is a potent human G-protein-coupled glucagon receptor (GCGR) negative allosteric modulator (NAM) with an IC50 of 69.2 nM. |
price> |
R-R-2826 |
Lixisenatide acetate CAS No.1997361-87-1 |
Lixisenatide acetate/CAS No.1997361-87-1 is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). |
price> |
R-R-2827 |
GLP-1 moiety from Dulaglutide CAS No.1197810-60-8 |
GLP-1 moiety from Dulaglutide/CAS No.1197810-60-8 is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist, extracted from patent US 20160369010 A1. |
price> |
R-R-2828 |
GLP-1R agonist 2 CAS No.281209-71-0 |
GLP-1R agonist 2 (compound 2)/CAS No.281209-71-0 is a potent GLP-1R agonist. GLP-1R agonist 2 has the potential for the research of metabolic diseases like Type2 Diabetes and Obesity. |
price> |
R-R-2829 |
Survodutide CAS No.2805997-46-8 |
Survodutide (BI 456906)/CAS No.2805997-46-8 is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide has robust anti-obesity efficacy achieved by increasing energy expenditure and decreasing food intake. |
price> |
R-R-2830 |
Glepaglutide acetate |
Glepaglutide (ZP1848) acetate, a long-acting GLP-2 analogue, is a potent GLP-2R agonist. Glepaglutide acetate reduces faecal output and increases intestinal absorption. Glepaglutide acetate alleviates small intestinal inflammation. |
price> |